Genome engineering by use of optimized TALENs, ZFNs, and CRISPR/Cas9 systems has accelerated early drug discovery efforts.  In this symposium, we discuss state-of-the-art methods and applications with a view to translating basic biology to novel medical therapies.  

Symposium sessions will highlight how scientists are applying genome engineering to create more physiologically and genetically relevant model systems, including those derived from stem cells, to answer disease biology questions and functionally validate new drug targets.

Speaker Invitations are in progress. Please use the Submit an Abstract link to let us know of your interest, whether you would like to speak, participate on the planning committee, partner, or sponsor/exhibit at this program.

Topics Include:

  • A genome engineering primer
  • Current technologies & techniques
  • Optimal reagent design and utilization
  • Applications in drug discovery and development
  • Modifying stem cells and deriving relevant lineages
  • Therapeutic applications
  • Creating disease appropriate model systems 
  • Building partnerships for rapid advancement of the field

Open to All!

Advancing Drug Discovery Through Genome Engineering is hosted by Merck Research Laboratories in the spirit of fostering collaborations among and with the the many industry and academic institutions in the Boston-Cambridge area.  Produced by the non-profit BioPharma Research Council  and managed by PlanetConnect, this event is designed to share best practices and introduce cutting-edge applications within the community.

For information on Sponsoring/Exhibiting, Click Here or
Contact Diane Sickles at PlanetConnect:   732-403-3139

Event Sponsors


Event Exhibitors


Associate Principal Scientist
Director, Applied Genomics
Director, Licensing
Director, Pharmacology
Distinguished Scientist
Executive Director
Executive Director, BD&L
Executive Director, BD&L Transactions
Executive Director, In Vitro Pharmacology
Principal Scientist
Senior Research Scientist
Senior Scientist
Senior Principal Scientist
SVP, Preclinical Development
V.P. & Therapeutic Area Biology Head,
        Cardiovascular, Diabetes & Bone
Vice President/Pharmacology & SPS

Advancing Drug Discovery Through Genome Engineering is hosted at the Merck Boston Facility. This is a program organized and solely supported by the BioPharma Research Council, PlanetConnect, and our exhibitor/sponsors.